Supplementary Table 1.

Included, and excluded studies according to primary hematological parameters.

Clinical outcomes and biomarkers	Studies were identified and screened [n]	Studies were excluded according to title, abstract or full text (Secondary exclude) [n]	Studies were included [n]	Data for occurrence and recurrence [n]
Platelet count	292	254	38 approved articles with totally 52 enrolled data for meta-analysis (48 studies	Occurrence: 48 Recurrence: 4
Mean platelet volume	147	129	18 approved articles with totally 24 enrolled data for meta-analysis	Occurrence: 23 Recurrence: 1
Platelet distribution width	11	9	2 approved articles with totally 3 enrolled data for meta-analysis	Occurrence: 3 Recurrence: 0
White blood cell	348	299	49 approved articles with totally 64 enrolled data for meta-analysis	Occurrence: 42 Recurrence: 22
Neutrophil to lymphocyte ratio	41	26	15 approved articles with totally 17 enrolled data for meta-analysis	Occurrence: 10 Recurrence: 7
Red blood cell	83	81	2 approved articles with totally 2 enrolled data for meta-analysis	Occurrence: 2 Recurrence: 0
Red blood cell distribution width	49	38	11 approved articles with totally 13 enrolled data for meta-analysis	Occurrence: 8 Recurrence: 5